Notification2024-06-27T20:53:49+00:00
1803, 2026

Why Coaching MSLs Matters: How the Right Approach Drives Better Scientific Engagement

By |March 18th, 2026|Blog|

Consider this fair warning, we’re about to say the one word that makes MSLs a little twitchy - sales. Coaching has long been recognized as a critical driver of sales performance. In most organizations, it is embedded into daily operations: managers coach representatives, ride‑a-longs are documented, and feedback is structured and measurable. Over time, these [...]

1603, 2026

Reintroducing iContracts: Reimagining a Market Leading Revenue Management Platform

By |March 16th, 2026|Blog|

For years, iContracts set the standard for revenue management in life sciences. Today, we are proud to reintroduce the platform, strengthened through new investment, enhanced functionality, and a renewed commitment to delivering the most comprehensive, purpose-built Revenue Management solution in the market. This is more than an enhancement. It is a strategic recommitment to the [...]

1603, 2026

Operationalizing Scientific Exchange: How Medical Affairs Delivers Measurable Impact

By |March 16th, 2026|Resources|

Today, Medical Affairs has achieved digitization, but digital alone is no longer enough. To meet rising expectations from regulators, leadership, and global compliance environments, teams must operationalize scientific exchange: embedding governance, consistency, and visibility directly into daily workflows. This eBook explores how purpose‑built technology, connected governance, and AI‑enabled insight capture can help Medical Affairs [...]

2602, 2026

Confidential Information (CI): A Board-Level Risk Hiding in Plain Sight

By |February 26th, 2026|Blog|

For life sciences executives, intellectual property risk is typically framed around patents, exclusivity periods, and litigation exposure. Yet an increasing risk to enterprise value sits outside traditional IP modeling: the disclosure of commercially sensitive information through expanding regulatory transparency frameworks. As global regulators increase public access to clinical and regulatory submissions, disclosure is no longer [...]

402, 2026

5 Survival Lessons from the Life Sciences Coaching Trenches

By |February 4th, 2026|Blog|

As coaches and managers, we spend a lot of time and energy making sure our employees are okay. We worry about how to give feedback in a way that will build them up and give them confidence to grow. We worry about how to talk and listen effectively. We stay up at night strategizing how [...]

2001, 2026

Why Life Sciences Companies Are Choosing Integrated SaaS Platforms Over Point Solutions to Ensure Compliant Growth

By |January 20th, 2026|Blog|

In today’s highly regulated, data-driven, and competitive life sciences environment, pharmaceutical, biotech, and medical device companies face increasing pressure to operate faster, more efficiently, and more intelligently. From commercial operations and regulatory compliance to supply chain management and financial planning, the number of business-critical processes that must work in harmony has never been greater. Traditionally, [...]

601, 2026

Medispend and RLDatix Life Sciences Complete Merger, Uniting Under the Medispend Brand to Create The Leading Life Sciences Compliance Software-as-a-Service Provider

By |January 6th, 2026|News|

PORTSMOUTH, Jan. 6, 2026 – Medispend and RLDatix Life Sciences today announced the successful completion of their merger, creating a unified organization that will operate under the Medispend name. The combined company offers a comprehensive suite of enterprise software and services for global regulatory and commercial compliance, medical affairs, field enablement and revenue management solutions [...]

312, 2025

State Price Transparency Solution Summary Download

By |December 3rd, 2025|Resources|

Download our State Price Transparency Solution summary to see how MediSpend helps life sciences teams simplify state drug pricing transparency—from strategic drug price modeling to effortless end-to-end statutory reporting. You’ll learn how our platform supports comprehensive compliance tracking with real-time updates and a built-in compliance calendar, plus proactive legislative monitoring and forecasting to keep [...]

1811, 2025

Making Sense of FMV: Strategies for the Life Sciences Industry

By |November 18th, 2025|Blog|

Introduction Fair Market Value (FMV) remains a central focus within the life sciences industry, as underscored at the recent Pharmaceutical and Medical Device Ethics and Compliance Congress. As the regulatory environment continues to evolve, companies are under increasing scrutiny regarding the appropriateness of compensation paid to healthcare professionals (HCPs). Corporate integrity agreements repeatedly highlight deficiencies [...]

Go to Top